Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.
BKK:VIBHA's 9-Day RSI is ranked better than 87.12% of 699
companies
in the Healthcare Providers & Services industry
Industry Median: 48.59
vs BKK:VIBHA: 30.69
Vibhavadi Medical Center PCL (BKK:VIBHA) 9-Day RSI Explanation
The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.
Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.
RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.
Vibhavadi Medical Center PCL 9-Day RSI Related Terms
BKK:VIBHA vs HCA, THC, DVA: 9-Day RSI Comparison
For the Medical Care Facilities subindustry, Vibhavadi Medical Center PCL's 9-Day RSI, along with its competitors' market caps and 9-Day RSI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Vibhavadi Medical Center PCL 9-Day RSI vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Vibhavadi Medical Center PCL's 9-Day RSI distribution charts can be found below:
* The bar in red indicates where Vibhavadi Medical Center PCL's 9-Day RSI falls into.
Vibhavadi Medical Center PCL (BKK:VIBHA) 9-Day RSI Calculation
The formula for calculating RSI is:
RSI
=
100
–
[ 100
/
( 1 + Average Gain
/
Average Loss )]
* Note that the formula uses a positive value for the average loss.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Vibhavadi Medical Center PCL (BKK:VIBHA) has a 9-Day RSI of 30.69 as of Jul. 21, 2026. According to the industry distribution chart, Vibhavadi Medical Center PCL ranks #90 out of 699 companies in the Healthcare Providers & Services industry, placing it in the top 12.9%.
Is Vibhavadi Medical Center PCL's 9-Day RSI too high?
Vibhavadi Medical Center PCL's current 9-Day RSI is 30.69. The Healthcare Providers & Services industry median 9-Day RSI is 48.59. Vibhavadi Medical Center PCL's value of 30.69 is 36.8% below this industry median. Based on the distribution chart, Vibhavadi Medical Center PCL ranks #90 out of 699 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Vibhavadi Medical Center PCL has a GF Score™ of 70/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Vibhavadi Medical Center PCL's 9-Day RSI compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Vibhavadi Medical Center PCL ranks #90 out of 699 companies for 9-Day RSI. This places Vibhavadi Medical Center PCL in the top 13% of its industry — outperforming the majority of peers. The industry median 9-Day RSI is 48.59. Vibhavadi Medical Center PCL's value of 30.69 is 36.8% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 9-Day RSI for a Healthcare Providers & Services company?
The median 9-Day RSI among Healthcare Providers & Services companies is 48.59, based on 699 companies in the industry. Companies in the top quartile (top 25%) have a 9-Day RSI significantly above this median, while those in the bottom quartile fall well below. However, 9-Day RSI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Vibhavadi Medical Center PCL's current 9-Day RSI of 30.69 is 36.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 9-Day RSI mean?
A high 9-Day RSI can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median 9-Day RSI is 48.59 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Vibhavadi Medical Center PCL's current 9-Day RSI is 30.69. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vibhavadi Medical Center PCL stock overvalued right now?
Based on GuruFocus' analysis, Vibhavadi Medical Center PCL (BKK:VIBHA) is currently considered Modestly Undervalued. The stock's GF Value™ is ฿1.70, compared to a current price of ฿1.34 — trading 21.2% below its estimated fair value. The current 9-Day RSI is 30.69 and 36.8% below the Healthcare Providers & Services industry median of 48.59. Vibhavadi Medical Center PCL's overall GF Score™ is 70/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 9-Day RSI calculated?
9-Day RSI is calculated from a company's financial statements. For Vibhavadi Medical Center PCL (BKK:VIBHA), the current 9-Day RSI is 30.69 as of Jul. 21, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Vibhavadi Medical Center PCL (BKK:VIBHA) Overvalued in 2026?
Based on GuruFocus' analysis, Vibhavadi Medical Center PCL stock appears to be undervalued.
The current stock price of ฿1.34 is trading 21.2% below its estimated GF Value™ of ฿1.70.
GuruFocus considers Vibhavadi Medical Center PCL to be Modestly Undervalued.
Key valuation signals for BKK:VIBHA:
9-Day RSI: 30.69
GF Value™: ฿1.70 vs. price of ฿1.34 (21.2% below fair value)
Industry Position: 36.8% below the Healthcare Providers & Services median (#90 of 699)
No single metric tells the full story. See the BKK:VIBHA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Vibhavadi Medical Center PCL provides the medical services known as Vibhavadi Hospital. The services provided include Pediatric Diseases, General Surgery, Orthopedic Center, General Medicine, Women's Health, Gastrointestinal Center, Cardiology, Neurology, Brain Tumor Surgery, Gamma Knife Radiosurgery for Brain, Cancer, Respiratory Diseases, Plastic Surgery, ENT (Ear, Nose, Throat) Department, Dental Center, Life Style Health Screening Center, Lasik Center, Eye, Hemodialysis Department, Dermatology Center, and Other Clinics and Services. Its segments include Hospital provides general hospital and hospital in social security; and Others provide rental services and rental space. The majority of the revenue is derived from the Hospital segment.
70GF Score
Get the complete analysis for BKK:VIBHA
9-Day RSI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:VIBHA has been successfully added to your 
